Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2012
10/10/2012EP2507225A1 L -dihydro-2-oxoquinoline compounds a 5-ht4 receptor ligands
10/10/2012EP2507224A1 Tetrahydroquinoline indole derivatives as monoamine reuptake inhibitors
10/10/2012EP2507223A1 Benzpyrazole derivatives as inhibitors of p13 kinases
10/10/2012EP2507211A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
10/10/2012EP2507210A1 Cyclohexane derivatives as inhibitors of acetyl-coa carboxylase (acc)
10/10/2012CN102725283A Compounds and compositions as protein kinase inhibitors
10/10/2012CN102725282A Fungicide hydroximoyl-tetrazole derivatives
10/10/2012CN102725281A Azole derivatives as WTN pathway inhibitors
10/10/2012CN102725268A Compounds for electronic devices
10/10/2012CN102724970A Tablet formulations of neratinib maleate
10/10/2012CN102718759A Heterocyclic CETP inhibitors
10/10/2012CN102718755A Cis nitenpyram compound with amide flexible bond and preparation method and application thereof
10/10/2012CN102718754A Method for preparing 5-methoxy-2-[[(4-methoxy-3, 5-dimethyl-pyridyl)-methyl]-sulfhydryl]-1H-benzimidazole
10/10/2012CN102718753A Pimeprazole crystal form A
10/10/2012CN102718752A Pimeprazole crystal form C
10/10/2012CN102718751A Pantoprazole salt crystal form and preparation method thereof
10/10/2012CN102718750A Aminopyridine derivatives containing acridine ring and application thereof
10/10/2012CN102718749A Preparation method of antitumor drug Nuonatini
10/10/2012CN102718748A Compounds having analgesic and/or immunostimulant activity
10/10/2012CN102718747A Olprinone hydrochloride derivate and synthetic method thereof
10/10/2012CN102718746A Trioxymethylene fumarate crystal form A and pharmaceutical usage thereof
10/10/2012CN102718745A Novel amino pyridine compound, its preparation method, pharmaceutical composition containing compound and application thereof
10/10/2012CN102718721A 4,4-disubstituted-dihydrogen-2(1H)-quinazolone or thioketone compound, synthetic method and application thereof
10/10/2012CN102718714A Anthracene-bridged tetradentate imidazole salt and preparation method and application thereof
10/10/2012CN102718708A Novel nitrogen-containing heteroaryl compounds and methods of use thereof
10/10/2012CN102718702A Aminopyridine derivatives and application thereof
10/10/2012CN102718679A Preparation method of Nuonatini key intermediate
10/10/2012CN101987847B Novel heterocyclic NF-kB inhibitors
10/10/2012CN101541764B Pyrimidylmethyl-sulfonamide compounds useful as fungicides and against arthropods
10/10/2012CN101450934B Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/10/2012CN101405285B Cyclic-alkylaminederivatives as inhibitors of the interaction between MDM2 and P53
10/10/2012CN101400670B Novel pyridine derivative having anti-helicobacter pylori activity
10/10/2012CN101360739B Label-free optical sensing and characterization of biomolecules by d8 or d10 metal complexes
10/10/2012CN101341125B New phenanthridine derivatives as bradykinin antagonists
10/10/2012CN101274932B 2-methyl-5- azomycin-1-(3-chloro-2-hydroxypropyl) chloro-substitutive derivate, preparation thereof and application thereof
10/10/2012CN101263112B Histamine H3 receptor agents, preparation and therapeutic uses
10/10/2012CN101142194B Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors
10/10/2012CN101090739B 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)amino]-6-methyl-perhydro-1,4-diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri)
10/10/2012CN101023074B Inhibitors of the interaction between MDM2 and P53
10/10/2012CN101018772B Neurologically-active compounds
10/09/2012US8283474 Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors
10/09/2012US8283365 Indole modulators of the alpha 7 nicotinic acetylcholine receptor
10/09/2012US8283363 Carboxamide compounds and their use as calpain inhibitors
10/09/2012US8283354 Quinazolines useful as modulators of ion channels
10/09/2012US8283351 Inhibiting cyctic fibrosis transmembrane conductance regulator polypeptide ; therapy for diarrhea and polycystic kidney disease
10/09/2012CA2674803C Quinazoline derivatives as angiogenesis inhibitors
10/09/2012CA2673435C Succinate salt of 2-((4-(1-methyl-4-(pyridin-4-yl)-1h-pyrazol-3-yl) phenoxy)methyl)quinoline
10/09/2012CA2575874C Crystalline form of a biphenyl compound
10/09/2012CA2551788C Novel carboxamides for use as xa inhibitors
10/09/2012CA2526455C 5-membered heterocycle-based p38 kinase inhibitors
10/09/2012CA2507100C 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
10/09/2012CA2476594C Mono-and bicyclic azole derivatives that inhibit the interaction of ligands with rage
10/04/2012WO2012135669A1 Nitrogen ring containing compounds for treatment of inflammatory disorders
10/04/2012WO2012135570A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
10/04/2012WO2012135160A1 (alpha- substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5 -triazinyl benzimidazoles, pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases
10/04/2012WO2012135009A1 Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
10/04/2012WO2012134206A2 Process for the preparation of anhydrous aripiprazole crystal form ii
10/04/2012WO2012133607A1 Pyrazole compound
10/04/2012WO2012133509A1 Novel benzimidazole derivative
10/04/2012WO2012133489A1 Pharmaceutical composition for treatment or prophylaxis of neurogenic diseases
10/04/2012WO2012133416A1 Method for producing phenoxypyridine derivative
10/04/2012WO2012131711A1 Improved process for preparation of imatinib and its mesylate salt
10/04/2012WO2012131588A1 3-ureidoisoquinolin-8-yl derivatives
10/04/2012WO2012130917A1 Quinoline derivatives as fungicides
10/04/2012WO2012130905A1 Substituted benzimidazoles
10/04/2012WO2012130166A1 1-(arylmethyl)quinazoline-2,4(1h,3h)-diones as parp inhibitors and the use thereof
10/04/2012WO2012130160A1 Aminopyridine derivatives containing acridine ring and use thereof
10/04/2012WO2012130159A1 Aminopyridine derivatives and uses thereof
10/04/2012WO2012129967A1 New aminopyridine compounds, the preparation method, the pharmaceutical compositions comprising these compounds and the uses thereof
10/04/2012WO2012104863A3 Process for controlling the content of single enantiomer of omeprazole
10/04/2012WO2012097121A9 Specific nnos inhibitors for the therapy and prevention of human melanoma
10/04/2012WO2012090179A3 Isoquinoline derivatives as cannabinoid receptor modulators
10/04/2012WO2012077136A3 Process for the preparation of benzimidazole derivatives and its salts
10/04/2012WO2009116072A3 Process for preparation of pyridinylmethylsulphinyl benzimidazole compounds and pyridine intermediates
10/04/2012US20120253041 New phenylalanine derivatives
10/04/2012US20120252847 Novel form of s-omeprazole
10/04/2012US20120252844 2,6-dioxo-3-deutero-piperdin-3-yl-isoindoline compounds
10/04/2012US20120252843 Isoindoline compounds and methods of their use
10/04/2012US20120252841 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators
10/04/2012US20120252810 Fatty acid non-flushing niacin derivatives and their uses
10/04/2012US20120252809 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
10/04/2012US20120252808 Quinoline amide m1 receptor positive allosteric modulators
10/04/2012US20120252807 Arbovirus inhibitors and uses thereof
10/04/2012US20120252790 Amino-Derivatives As Novel Inhibitors Of Histone Deacetylase
10/04/2012US20120252789 Inhibitors of sphingosine kinase
10/04/2012US20120252770 Chemical Compounds 572
10/04/2012US20120252758 Novel Bicyclic Pyridinones
10/04/2012US20120252740 Hdac inhibitors and therapeutic methods of using same
10/04/2012US20120252670 Pyridinecarboxamides, useful-plant-protecting composition comprising them and processes for their preparation and their use
10/04/2012US20120252125 Ethylene oxide sterilization indicator compositions
10/04/2012US20120251551 Substituted (Heteroarylmethyl)thiohydantoins
10/04/2012US20120251491 Fused tricyclic aryl compounds useful for the treatment of viral diseases
10/04/2012US20120247561 4,4'-dicarboxy-2,2'-bipyridine derived tridentate ligand, metal complex containing the same, and application thereof
10/04/2012CA2831710A1 Substituted benzimidazoles as mps-1 kinase inhibitors
10/04/2012CA2831582A1 (alpha- substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5 -triazinyl benzimidazoles , pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases
10/04/2012CA2831015A1 1-(arylmethyl)quinazoline-2,4(1h,3h)-diones as parp inhibitors and the use thereof
10/04/2012CA2828423A1 3-ureidoisoquinolin-8-yl derivatives
10/04/2012CA2826404A1 Method for producing phenoxypyridine derivative
10/03/2012EP2505586A1 Indole compound and pharmaceutical use thereof
10/03/2012EP2505200A1 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of scleroderma
1 ... 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 ... 1080